Observational studyBMC pediatrics2026
Development and validation of a clinical prediction model for gastrointestinal hemorrhage in pediatric IgA vasculitis.
Observational study in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo develop and internally validate a preliminary clinical prediction model for incident gastrointestinal hemorrhage (GH) occurring after admission in children with IgA vasculitis (IgAV), with continuous laboratory predictors retained in original scale to maximize predictive information.
methodsSingle-center retrospective cohort including 662 pediatric IgAV patients (2016-2022). The primary derivation cohort comprised 599 patients without overt bleeding on admission, among whom 126 (21.0%) developed delayed-onset GH ≥ 24 h post-admission. Eight admission-based predictors were selected for the Primary Continuous Model (PCM): abdominal pain, vomiting, neutrophil count, eosinophil count, mean platelet volume, albumin, complement C3, and IgA. D-dimer was excluded from the PCM because restricted cubic spline analysis demonstrated a significant non-linear, threshold-dependent relationship rather than a linear association with GH risk (P for non-linearity = 0.032); it was subsequently incorporated into the Simplified Bedside Score (SBS) via its clinically established dichotomous cutoff of 210 µg/L. Multivariable logistic regression with Enter method was performed. Internal validation included 1000-bootstrap resampling, Hosmer-Lemeshow calibration assessment, and decision curve analysis. A simplified dichotomized nine-point bedside scoring system was derived post hoc for clinical triage.
resultsThe primary eight-variable continuous model achieved an apparent AUC of 0.790 (95% CI: 0.748-0.832) and a bootstrap optimism-corrected AUC of 0.763. Calibration was excellent (Hosmer-Lemeshow P = 0.917). Five predictors demonstrated independent association with delayed-onset GH (P < 0.05): abdominal pain, vomiting, neutrophil count, MPV, and C3. The simplified dichotomized bedside scoring system yielded a corrected AUC of 0.779, with sensitivity of 77.0% and specificity of 70.2%. Restricted to clinically significant overt severe GH (n = 102), the corrected AUC increased to 0.801.
conclusionThis admission-based preliminary prediction model achieves moderate discrimination for post-admission GH in pediatric IgAV. The primary continuous model preserves predictive information, while a simplified dichotomized scoring system facilitates bedside triage. In conclusion, this admission-based model preserves substantial predictive information and provides a validated baseline framework; we now propose and open this simplified dichotomized scoring system for external validation across international multicenter pediatric cohorts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.